Skip to content

EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients

EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04443517
Acronym
ALPHA-DEX
Enrollment
600
Registered
2020-06-23
Start date
2026-04-01
Completion date
2031-03-31
Last updated
2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Keywords

EEG, General Anesthesia

Brief summary

The investigators intend to recruit 600 participants to see if alpha power during anesthesia is influenced by analgesic medication and associated with a reduction of delirium following surgery.

Detailed description

Postoperative delirium may manifest in the immediate post-anesthesia care period. Such episodes appear to be predictive of further episodes of inpatient delirium and associated adverse outcomes. Intraoperative monitoring of frontal electroencephalogram (EEG) has been associated with postoperative delirium and poor outcomes. However, the efficacy of titrating anesthesia medication to proprietary index targets for preventing delirium remains contentious. The investigators aim to assess the efficacy of two pharmacologic strategies which could prevent post-anesthesia care unit (PACU) delirium (1) maximization of intraoperative alpha power during maintenance and (2) switching anesthesia regimes during the emergence phases of anesthesia.

Interventions

PROCEDUREAlpha Optimization

Intraoperative oscillatory EEG alpha optimization involves real-time acquisition of oscillatory alpha power from the frontal EEG with individualized titration of sevoflurane and opioid.

BEHAVIORALEmergence from anesthesia with Dexmedetomidine

Infusion of .05 mcg/kg/h of propofol during the final 10-20 minutes of surgery.

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 60 years or over * Has capacity to provide informed consent * Undergoing elective non-cardiac surgery, which does not involve the head or neck, with planned volatile-based general anesthesia of expected duration of at least 2 hours

Exclusion criteria

* Chronic pain with opioid requirement or concurrent use of enzyme inducers, e.g. carbamazepine, phenytoin, * Illicit substance use or excessive alcohol intake * Refusal by patient or case anesthesiologist responsible for patient's care

Design outcomes

Primary

MeasureTime frameDescription
Change in Frontal Alpha PowerUp to 24 hours post-surgeryThe EEG data collected during the study duration will be processed using a customized script. Frontal alpha power (i.e., the cumulative power in the EEG alpha range) will be extracted from the EEGs and analyzed to compare the groups for the differences in the frontal alpha power.

Secondary

MeasureTime frameDescription
Incidence of PACU DeliriumUp to 24 hours post-surgery3-Minute Diagnostic Interview for Confusion Assessment Method(3D-CAM), Confusion Assessment Method for the ICU (CAM-ICU), Speech / Language Assessment will be administered to check for signs of delirium.
Change in pain in PACU: numerical rating score (NRS)Up to 24 hours post-surgeryThe numerical rating score (NRS) requires the patient to rate their pain from 0-10 where 0 is no pain and 10 is the worst pain imaginable (high score indicates worse outcome).

Countries

United States

Contacts

Primary ContactPaul S. Garcia, MD, PhD
pg2618@cumc.columbia.edu212-304-7678
Backup ContactTuan Z. Cassim, BA
tc3032@cumc.columbia.edu917-539-9926

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026